NCT07148414Phase 2Active not recruiting

A Study of SPY072 in Rheumatic Disease

Study sponsor: Spyre Therapeutics, Inc. · SYRE

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-10-31Estimated
Enrollment · participants285Estimated
Source updated2026-06-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview